Autopsy report · NCT02090569
High Resolution Imaging of Cerebral Vasculature by Functional Micro-Doppler Sonography During Brain Surgery
Cause of deathSafety
“recommandation of the Data Safety monitoring Board”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 6 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Centre Hospitalier St Anne
- Sponsor type
- University, hospital or other
- Conditions
- Partial Drug-resistant Epilepsy
- Interventions
- Functional micro-Doppler Sonography (fmDS)
- Participants
- 3
- Sites
- 1
- Countries
- France
Trials that died the same way
- The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
“Data Safety Monitoring Board concerning of the participants' safety” - Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
“Following a recommendation from the Data Safety Monitoring Board (DSMB).” - Lithium in Multiple System Atrophy
“Data Monitoring Committee decision on 22nd August 2011 for safety issues” - Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
“following a recommendation from the data safety and monitoring board due to safety concerns and a tendency towards futility.” - Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
“Data Safety Monitoring Board (DSMB) recommended stopping study due to futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.